Trials / Withdrawn
WithdrawnNCT06545344
Palliative Care Consultation to Improve Communication for Patients Considering Surgery for a Pancreatic Neoplasm
Preoperative, Specialty Palliative Care for Patients Considering Pancreatic Surgery: Pilot Feasibility and Acceptability Study
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Fred Hutchinson Cancer Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This clinical trial evaluates a palliative care consultation for improving communication between providers and patients considering surgery for a pancreatic neoplasm. Pancreatic operations have known complications that can affect quality of life. Palliative care has been shown to improve patient reported quality of life and functional outcomes. Receiving a palliative care consultation may improve communication and decision making for patients considering surgery for a pancreatic neoplasm.
Detailed description
OUTLINE: Patients are randomized to 1 of 2 arms. ARM I: Patients receive usual care and undergo evaluation by a tumor board within 14 days of baseline. ARM II: Patients attend a palliative care visit over 60 minutes to discuss their illness, quality of life, fears and concerns and communication preferences within 7 days of baseline. Patients also undergo evaluation by a tumor board within 14 days of baseline. After completion of study intervention, patients are followed up 7 days after the tumor board visit and 90 days after initiation of treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Best Practice | Receive usual care |
| PROCEDURE | Palliative Care Consultation | Attend a palliative care visit |
| OTHER | Survey Administration | Ancillary studies |
| OTHER | Tumor Board Review | Undergo evaluation by tumor board |
Timeline
- Start date
- 2025-09-01
- Primary completion
- 2026-01-01
- Completion
- 2026-01-01
- First posted
- 2024-08-09
- Last updated
- 2025-06-29
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06545344. Inclusion in this directory is not an endorsement.